What you'll learn
- Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
- Managing refractory pouchitis
- GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
- Antiviral therapies for hepatitis B and C: how to select which regimen to use? Understanding long-term risks of therapy
- See the course registration details for additional topics
Course description
This is an accredited, livestreamed course offered by Massachusetts General Hospital, Brigham Health, and Beth Israel Deaconess Medical Center. This course is targeted to Gastroenterologists, Internists, Surgeons, Nurse Practitioners, Physician Assistants.
Select the Take Course button to view additional information on the course registration page.
Contact ceprograms@hms.harvard.edu with questions.
*Register before May 20 to receive the discounted price.
Associated Schools
Harvard Medical School
Enroll now.
Take courseYou may also like
Learn about the latest evidenced-based medicine and guidelines for diagnosing, treating, and managing the care of patients with...$49Register byMay 5- This case-based, multiple question course will review current guidelines for patients with a variety of lipid disorders.$99Register byMay 19
- This course will focus on adult DVT patients with an emphasis upon testing, anticoagulant therapy, and inherited thrombophilia.$49Register byJun 17
